Merit Medical Systems (NASDAQ:MMSI) Insider Brian Lloyd Acquires 2,000 Shares

Merit Medical Systems, Inc. (NASDAQ:MMSI) insider Brian Lloyd purchased 2,000 shares of the stock in a transaction dated Thursday, May 7th. The stock was purchased at an average price of $62.62 per share, with a total value of $125,240.00. Following the completion of the acquisition, the insider directly owned 2,000 shares in the company, valued at approximately $125,240. The trade was a ∞ increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link.

Merit Medical Systems Trading Down 1.6%

Merit Medical Systems stock opened at $60.31 on Tuesday. The company has a market cap of $3.60 billion, a P/E ratio of 26.11, a PEG ratio of 1.91 and a beta of 0.58. Merit Medical Systems, Inc. has a 1 year low of $59.74 and a 1 year high of $100.19. The firm’s 50-day moving average is $68.73 and its 200-day moving average is $79.04. The company has a debt-to-equity ratio of 0.45, a quick ratio of 3.46 and a current ratio of 5.08.

Merit Medical Systems (NASDAQ:MMSI) last issued its earnings results on Thursday, April 30th. The medical instruments supplier reported $0.94 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.84 by $0.10. The firm had revenue of $381.88 million for the quarter, compared to analysts’ expectations of $377.59 million. Merit Medical Systems had a net margin of 9.03% and a return on equity of 13.54%. Merit Medical Systems’s revenue was up 7.4% on a year-over-year basis. During the same quarter last year, the company posted $0.86 earnings per share. Merit Medical Systems has set its FY 2026 guidance at 4.010-4.150 EPS. On average, equities analysts expect that Merit Medical Systems, Inc. will post 3.61 earnings per share for the current year.

Analysts Set New Price Targets

MMSI has been the topic of several analyst reports. Canaccord Genuity Group lowered their target price on Merit Medical Systems from $90.00 to $85.00 and set a “buy” rating on the stock in a research report on Friday, May 1st. Compass Point set a $107.00 target price on shares of Merit Medical Systems in a report on Monday, April 20th. Robert W. Baird set a $83.00 price target on Merit Medical Systems in a research note on Friday, May 1st. Wall Street Zen downgraded shares of Merit Medical Systems from a “strong-buy” rating to a “buy” rating in a research note on Sunday, April 5th. Finally, Needham & Company LLC dropped their target price on Merit Medical Systems from $101.00 to $90.00 and set a “buy” rating on the stock in a report on Friday, May 1st. Eight analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $92.80.

Institutional Trading of Merit Medical Systems

Hedge funds have recently added to or reduced their stakes in the business. Los Angeles Capital Management LLC bought a new stake in shares of Merit Medical Systems in the fourth quarter valued at approximately $25,000. Maseco LLP acquired a new stake in shares of Merit Medical Systems during the 4th quarter valued at about $26,000. Torren Management LLC bought a new stake in shares of Merit Medical Systems in the 4th quarter valued at approximately $38,000. Covestor Ltd grew its position in Merit Medical Systems by 252.6% in the fourth quarter. Covestor Ltd now owns 469 shares of the medical instruments supplier’s stock valued at $41,000 after acquiring an additional 336 shares during the period. Finally, Danske Bank A S bought a new stake in shares of Merit Medical Systems in the 3rd quarter worth about $42,000. Institutional investors own 99.66% of the company’s stock.

Merit Medical Systems Company Profile

Merit Medical Systems, Inc is a global manufacturer and marketer of a broad range of medical devices used in diagnostic and interventional procedures. The company’s product portfolio encompasses vascular access, drainage, embolotherapy, and interventional oncology devices, as well as radiofrequency ablation systems and hemostasis solutions. These products serve physicians and hospitals in critical care settings and support minimally invasive treatment options across multiple specialties, including cardiology, radiology, oncology, neurology and endoscopy.

Founded in 1987 by Fred Lampropoulos, Merit Medical Systems has grown through both organic development and targeted acquisitions to expand its technology offerings and geographic reach.